Impaired inhibitory function of presynaptic a1-adenosine receptors in SHR mesenteric arteries

Journal of Pharmacological Sciences

Volumn 122, Issue 2, 2013, Pages 59-70

  Rocha Pereira, Carolina ^a   Arribas, Silvia Magdalena ^b   Fresco, Paula ^a   González, Maria Carmen ^b   Gonçalves, Jorge ^a   Diniz, Carmen ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Adenosine receptor; Confocal image; Hypertension; Mesenteric adventitia layer; Modulation

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; NORADRENALIN; PRESYNAPTIC RECEPTOR; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INNERVATION; BLOOD VESSEL REACTIVITY; BLOOD VESSEL WALL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HYPERTENSION; MALE; MESENTERIC ARTERY; MORPHOMETRICS; NONHUMAN; NORADRENALIN RELEASE; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; SYNAPSE; WISTAR KYOTO RAT;

EID: 84880793163     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.12266FP     Document Type: Article

References (39)

1. Diniz C, Borges F, Santana L, Uriarte E, Oliveira JM, Goncalves J, et al. Ligands and therapeutic perspectives of adenosine A(2A) receptors. Curr Pharm Des. 2008;14:1698-1722.
2. Diniz C, Fresco P, Leal S, Goncalves J. Adenosine receptors involved in modulation of noradrenaline release in isolated rat tail artery. Eur J Pharmacol. 2004;504:17-25.
3. Fresco P, Diniz C, Goncalves J. Facilitation of noradrenaline release by activation of adenosine A(2A) receptors triggers both phospholipase C and adenylate cyclase pathways in rat tail artery. Cardiovasc Res. 2004;63:739-746.
4. Fresco P, Diniz C, Queiroz G, Goncalves J. Release inhibitory receptors activation favours the A2A-adenosine receptor-mediated facilitation of noradrenaline release in isolated rat tail artery. Br J Pharmacol. 2002;136:230-236.
5. Wiklund NP, Cederqvist B, Gustafsson LE. Adenosine enhancement of adrenergic neuroeffector transmission in guinea-pig pulmonary artery. Br J Pharmacol. 1989;96:425-433.
6. Ralevic V. Sympathoinhibition by adenosine A(1) receptors, but not P2 receptors, in the hamster mesenteric arterial bed. Eur J Pharmacol. 2000;387:287-293.
7. Donoso MV, Aedo F, Huidobro-Toro JP. The role of adenosine A2A and A3 receptors on the differential modulation of norepi-nephrine and neuropeptide Y release from peripheral sympathetic nerve terminals. J Neurochem. 2006;96:1680-1695.
8. Guimaraes S, Albino-Teixeira A. Hypertension due to chronic blockade of P1-purinoceptors. J Auton Pharmacol. 1996;16: 367-370.
9. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, et al. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature. 1997;388:674-678.
10. Silva-Carvalho L, Dawid-Milner MS, Goldsmith GE, Spyer KM. Hypothalamic-evoked effects in cat nucleus tractus solitarius facilitating chemoreceptor reflexes. Exp Physiol. 1993; 78:425-428.
11. St Lambert JH, Dawid-Milner MS, Silva-Carvalho L, Spyer KM. Action of adenosine receptor antagonists on the cardiovascular response to defence area stimulation in the rat. Br J Pharmacol. 1994;113:159-164.
12. Barraco RA, Phillis JW. Subtypes of adenosine receptors in the brainstem mediate opposite blood pressure responses. Neuropharmacology. 1991;30:403-407.
13. Lo WC, Jan CR, Wu SN, Tseng CJ. Cardiovascular effects of nitric oxide and adenosine in the nucleus tractus solitarii of rats. Hypertension. 1998;32:1034-1038.
14. Illes P, Rickmann H, Brod I, Bucher B, Stoclet JC. Subsensitivity of presynaptic adenosine A1-receptors in caudal arteries of spontaneously hypertensive rats. Eur J Pharmacol. 1989;174: 237-251.
15. Arribas SM, Hillier C, Gonzalez C, McGrory S, Dominiczak AF, McGrath JC. Cellular aspects of vascular remodeling in hypertension revealed by confocal microscopy. Hypertension. 1997;30:1455-1464.
16. Somoza B, Abderrahim F, González JM, Conde MV, Arribas SM, Starcher B, et al. Short-term treatment of spontaneously hypertensive rats with liver growth factor reduces carotid artery fibrosis, improves vascular function, and lowers blood pressure. Cardiovasc Res. 2006;69:764-771.
17. Fresco P, Oliveira JM, Kunc F, Soares AS, Rocha-Pereira C, Goncalves J, et al. A2A adenosine-receptor-mediated facilitation of noradrenaline release in rat tail artery involves protein kinase C activation and betagamma subunits formed after alpha2-adrenoceptor activation. Neurochem Int. 2007;51:47-56.
18. Leal S, Diniz C, Sa C, Goncalves J, Soares AS, Rocha-Pereira C, et al. Semiautomated computer-assisted image analysis to quantify 3,3'-diaminobenzidine tetrahydrochloride-immunostained small tissues. Anal Biochem. 2006;357:137-143.
19. Leal S, Sa C, Goncalves J, Fresco P, Diniz C. Immunohisto-chemical characterization of adenosine receptors in rat aorta and tail arteries. Microsc Res Tech. 2008;71:703-709.
20. Starke K, Gothert M, Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev. 1989;69: 864-989.
21. Feoktistov I, Biaggioni I. Adenosine A2B receptors. Pharmacol Rev. 1997;49:381-402.
22. Bonisch H, Bruss M. The norepinephrine transporter in physiology and disease. Handb Exp Pharmacol. 2006:485-524.
23. McGrath JC, Arribas S, Daly CJ. Fluorescent ligands for the study of receptors. Trends Pharmacol Sci. 1996;17:393-399.
24. Daly CJ, Ross RA, Whyte J, Henstridge CM, Irving AJ, McGrath JC. Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries. Br J Pharmacol. 2010;159:787-796.
25. Eguchi S, Tezuka S, Hobara N, Akiyama S, Kurosaki Y, Kawasaki H. Vanilloid receptors mediate adrenergic nerve- and CGRP-containing nerve-dependent vasodilation induced by nicotine in rat mesenteric resistance arteries. Br J Pharmacol. 2004;142:1137-1146.
26. Esler M, Lambert G, Brunner-La Rocca HP, Vaddadi G, Kaye D. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiol Scand. 2003;177:275-284.
27. Diniz C, Rocha-Pereira C, Fresco P. Image analysis in microscopy-An historical perspective. Image Analysis in Life Science. In: Diniz C PS, editor. Trivandrum: Research Signpost; 2009. p. 1-18.
28. Acquarone N, Bertocchi I, De Ferrari G, Fresco G, Guerreri G, Menozzi PG, et al. [Corporeal intracellular pH in patients with chronic uremia]. Minerva Nefrol. 1971;18:92-97. (text in Italian)
29. Tsuda K, Kuchii M, Nishio I, Masuyama Y. Presynaptic alpha 2-adrenoceptor mediated regulation of norepinephrine release in perfused mesenteric vasculatures in young and adult spontaneously hypertensive rats. Jpn Circ J. 1987;51:25-32.
30. Bobalova J, Mutafova-Yambolieva V. Presynaptic alpha2-adre-noceptor- mediated modulation of adenosine 5' triphosphate and noradrenaline corelease: differences in canine mesenteric artery and vein. J Auton Pharmacol. 2001;21:47-55.
31. von Kügelgen I, Starke K. Noradrenaline-ATP co-transmission in the sympathetic nervous system. Trends Pharmacol Sci. 1991; 12:319-324.
32. Westfall TC, Badino L, Naes L, Meldrum MJ. Alterations in the field stimulation-induced release of endogenous norepinephrine from the coccygeal artery of spontaneously hypertensive and Wistar-Kyoto rats. Eur J Pharmacol. 1987;135:433-437.
33. Head RJ, Cassis LA, Robinson RL, Westfall DP, Stitzel RE. Altered catecholamine contents in vascular and nonvascular tissues in genetically hypertensive rats. Blood Vessels. 1985; 22:196-204.
34. Head RJ. Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels. 1989;26:1-20.
35. Scott TM, Pang SC. The correlation between the development of sympathetic innervation and the development of medial hypertrophy in jejunal arteries in normotensive and spontaneously hypertensive rats. J Auton Nerv Syst. 1983;8:25-32.
36. Kondo M, Fujiwara T, Miyazaki T, Terade M, Tabei R. Noradrenergic hyperinnervation may inhibit necrosis of coronary arterial smooth muscle cells in stroke-prone spontaneously hypertensive rats. Virchows Arch. 1997;430:71-75.
37. Luff SE, Young SB, McLachlan EM. Hyperinnervation of mesenteric arteries in spontaneously hypertensive rats by sympathetic but not primary afferent axons. J Vasc Res. 2005;42: 348-358.
38. Hasko G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov. 2008;7:759-770.
39. Feng W, Song Y, Chen C, Lu ZZ, Zhang Y. Stimulation of adenosine A(2B) receptors induces interleukin-6 secretion in cardiac fibroblasts via the PKC-delta-P38 signalling pathway. Br J Pharmacol. 2010;159:1598-1607.